Effect of Regular Exercise on Maternal Cardiovascular System During Pregnancy
Recruitment status was: Recruiting
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Supportive Care
|Official Title:||Effect of Supervised Exercise Program on Cardiovascular Function and Structure in Pregnant Women. Randomized Controlled Trial|
- Change from cardiovascular function at the end of pregnancy: Stroke volume [ Time Frame: Weeks 20 and 34 ]Data were collected in second and third trimester
- Change from cardiovascular structure at the end of the pregnancy [ Time Frame: Weeks 20 and 34 ]Data were collected in second and third trimester
- Maternal and fetal pregnancy outcomes [ Time Frame: During pregnancy. At the moment of delivery. ]Gestational age, type of delivery, duration of labor, maternal weight gain, birth weight, size and head circumference of new born, pH of umbilical cord, Apgar Score.
|Study Start Date:||February 2009|
|Estimated Study Completion Date:||September 2015|
|Primary Completion Date:||June 2014 (Final data collection date for primary outcome measure)|
No Intervention: Control
Sedentary pregnant women
|Experimental: Exercise group||
Behavioral: Exercise group
Supervised physical conditioning program of three 55—60 minute sessions per week during whole pregnancy (from week 9 to 38). Each session consists of 25-30 minutes of cardiovascular exercise,10 minutes of specific exercises (strength and balance exercises), and 10 minutes of pelvic floor muscles training
Aerobic activity was prescribed at light to moderate intensity, aiming for 55-60 of maximal heart rate. All subjects wore a heart rate (HR) monitor (Polar FT7) during the training sessions to ensure that exercise intensity was light to moderate.
During pregnancy, the effectiveness of cardiovascular system is necessary to the growth and development of the baby, however many changes in it occur during this period.
Physical exercise has shown to have a positive effect on cardiovascular structure and function in the general population.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01723098
|Universidad Politecnica de Madrid|
|Madrid, Spain, 28040|
|Study Director:||Ruben Barakat, PhD||Universidad Politecnica de Madrid|